NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

PCAS SA (PA: PCA)

 
PCA Technical Analysis
1.5
As on 8th Dec 2023 PCA STOCK Price closed @ 8.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 7.34 & Sell for SHORT-TERM with Stoploss of 8.28 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

PCASTOCK Price

Open 8.25 Change Price %
High 8.25 1 Day 0.00 0.00
Low 8.00 1 Week 0.00 0.00
Close 8.00 1 Month 0.10 1.27
Volume N/A 1 Year -1.28 -13.79
52 Week High 9.28 | 52 Week Low 5.90
 
PA France Most Active Stocks
FTI 5.91 -1.66%
VIEDS 0.72 4.35%
ALNEV 0.00 %
LAT 0.02 %
CGG 0.69 -2.82%
DSY 17.82 %
ACA 17.77 %
ETL 2.24 %
ORA 17.16 %
ENGI 26.09 %
 
PA France Top Gainers Stocks
2MX 7.46 8.43%
ATA 0.13 8.33%
ATA 0.13 8.33%
ATA 0.13 8.33%
ATA 0.13 8.33%
ATA 0.13 8.33%
ALTBG 2.88 8.27%
ALP 21.50 6.44%
ALP 21.50 6.44%
ALANT 4.68 6.36%
 
PA France Top Losers Stocks
AKOM 4.06 -37.05%
AKOM 4.06 -37.05%
FPN 0.02 -33.33%
ORP 7.90 -12.03%
MLMON 0.88 -12.00%
FALG 0.56 -8.20%
PROL 0.24 -7.69%
LFDE 44.20 -7.14%
ALD 6.87 -5.89%
ALD 6.87 -5.89%
 
 
PCA
Daily Charts
PCA
Intraday Charts
Whats New @
Bazaartrend
PCA
Free Analysis
 
PCA Important Levels Intraday
RESISTANCE8.48
RESISTANCE8.33
RESISTANCE8.23
RESISTANCE8.14
SUPPORT7.86
SUPPORT7.77
SUPPORT7.67
SUPPORT7.52
 
PCA Forecast February 2026
4th UP Forecast10.54
3rd UP Forecast9.73
2nd UP Forecast9.22
1st UP Forecast8.72
1st DOWN Forecast7.28
2nd DOWN Forecast6.78
3rd DOWN Forecast6.27
4th DOWN Forecast5.46
 
PCA Weekly Forecast
4th UP Forecast9.81
3rd UP Forecast9.23
2nd UP Forecast8.87
1st UP Forecast8.51
1st DOWN Forecast7.49
2nd DOWN Forecast7.13
3rd DOWN Forecast6.77
4th DOWN Forecast6.19
 
PCA Forecast2026
4th UP Forecast14.74
3rd UP Forecast12.58
2nd UP Forecast11.24
1st UP Forecast9.91
1st DOWN Forecast6.09
2nd DOWN Forecast4.76
3rd DOWN Forecast3.42
4th DOWN Forecast1.26
 
 
PCA Other Details
Segment EQ
Market Capital 162152064.00
Sector Basic Materials
Industry Chemicals
Offical website >
 
PCA Address
PCA
 
PCA Latest News
 
Your Comments and Response on PCAS SA
 
PCA Business Profile
PCAS SA develops and produces complex molecules for life sciences and technologies worldwide. It offers chemical and analytical development services for clinical active ingredients or advanced intermediates; and custom manufacturing services for pharmaceutical active ingredients or key intermediates. The company also engages in the development and production of active pharmaceutical ingredients; and production of reagents, building-blocks, and synthesis intermediates, as well as drug delivery systems, excipients, and biomaterials. In addition, it provides advanced specialty solutions, such as electronic materials, polymers and monomers, and cosmetic ingredients, as well as custom manufacturing services to various industries operating in sectors, including microelectronics, energy, environment, industrial processes, special polymers, and personal well-being. Further, the company offers performance chemicals comprising industrial lubricating additives, long term corrosion protection products, greases, and bio-sourced lubricants, as well as custom manufacturing and tooling services. PCAS SA was founded in 1962 and is headquartered in Longjumeau, France. PCAS SA operates as a subsidiary of Seqens SAS Address: BP 181 - 23 Rue Bossuet, Longjumeau, France, 91160
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service